ASY 23,0 -1,29%
The industrial sector of life sciences is a sustainably growing market, with constant demand driven by a continuous need for more innovative, effective and safer therapies from the public and governments.
With more competition and stringent regulatory requirements (GMP: Good Manufacturing Practises, Pharmacopeia), the industrial landscape requires new solutions.
Life sciences should also take advantage of disruptions offered by digital. These new solutions include new processes, new approaches but also the digitalisation of each step of the industrial life cycle, being for new therapies or new industrial investments. Leveraging these with proper risk management and adapted cybersecurity is the new challenge of the industry.
Faced with the massive emergence of new pathologies, the aging of the population and the increased demand from emerging countries, the healthcare and life science industry has to adapt its business model, organisation as well as industrial network and practices, in order to offer new solutions to a wider range of patients with increased requirements.
The challenge of complying to ever-changing regulatory requirements is high, at every step of the industrial life cycle, beginning with the startup of a new installation, to the operational organisation. To properly respond to this changing environment, adapted tools, methodologies and expertise are required. Anticipation is key in order to ensure compliance to current and future regulations, but also to optimize and simplify usual over-complex processes.
With more competition for your therapies comes more pressure to deliver on time, if not early. Product launch must happen quickly and your industrial organisation must lead the way. Lead times and cost control are paramount to optimise your operational processes at each step of the product life cycle. Reducing the startup lead times of new installations, increasing flexibility and optimising the cost of ownership by building on operational excellence practices and technical expertise are the cornerstones for bringing the new therapies that patients are waiting for.
The digital revolution is like a treasure hunt: find how and where to implement it and the gain will be tremendous. From product development to industrial process improvement or product life cycle management, digitalisation increases the efficiency and compliance to regulations of every task in your organisation. This will be a success if the key challenges of cybersecurity, data integrity and, in general, data life cycle management are tackled adequately.
Assystem supports players in Life Sciences and Health (Medicines & biomedicines, medical devices, diagnostics, agri-agro, fine chemicals, cosmetics, health services).
By combining the complex project engineering and digital engineering skills of Assystem with the compliance, quality and qualification-validation expertises of Assystem Care, we work on your processes, your equipment and your infrastructures, from strategy to operational activities. We take care of your industrial projects throughout their life cycle while optimizing your time-to-market.Our unique advisory offer integrates end-to-end engineering as well as quality and performance management throughout your whole industrial life cycle, with a transverse vision of systems engineering: from conception and engineering to batch release and operations optimisation. Starting from your challenges, our team of experts develops the customised solutions you need based on our methodologies and our own first-of-a-kind smart tools.
Assystem Care is a subsidiary of Assystem dedicated to Health and Life Sciences.
"The use of digital solutions enhance industrial performance on compliance issues and also when it comes to managing multi-party projects, supervising work and equipment, and providing oversight..."
"Blockchain offers a unique opportunity to provide stronger assurance about the authenticity and traceability of the data that underpins the safety of medical drugs and patients' healthcare."